Annual report pursuant to Section 13 and 15(d)

Equity Incentive Plan (Tables)

v3.23.1
Equity Incentive Plan (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense
Stock Options & SARs   Year ended
December 31,		  
(in thousands)   2022     2021  
General and administrative   $ 1,254     $ 933  
Sales and marketing     173       116  
Research and development     323       242  
Cost of revenues     89       96  
    $ 1,839     $ 1,387  

 

RSUs   Year ended
December 31,		  
(in thousands)   2022     2021  
General and administrative   $ 273     $
-
  
Sales and marketing    
-
      
-
  
Research and development    
-
      
-
  
Cost of revenues    
-
      
-
  
    $ 273     $ -  

 
Schedule of fair value of option grants weighted average assumptions
    December 31,  
    2022     2021  
Expected term (in years)     5.9       5.7  
Expected Volatility     54.8 %     54.3 %
Risk-free rate     2.2 %     0.8 %
Dividend rate    
—
      
—
  

 
Schedule of stock option activity
Stock Options & SARs  

Number of
Shares under

Option Plan

     Weighted-
Average
Exercise
Price per
Option		    

Weighted-

Average

Remaining

Contractual

Life (in
years)

  
Outstanding at December 31, 2021     6,583,381     $ 1.78       8.0  
Granted     1,893,674       1.19          
Exercised     (64,667 )   $ 0.77          
Forfeited and expired     (177,565 )   $ 2.89          
Outstanding at December 31, 2022     8,234,823     $ 1.82       7.7  
Exercisable at December 31, 2022     5,140,247     $ 1.44       7.0  
Vested and expected to vest at December 31, 2022     8,234,823     $ 1.82       7.7  

 

RSUs   Number of
Shares
under
Option Plan		     Weighted
Average
Grant Date
Fair Value		  
Outstanding at December 31, 2021    
-
     $
-
  
Granted     263,155       1.90  
Exercised      (- )   $
-
  
Forfeited and expired      (- )   $
-
  
Outstanding at December 31, 2022     263,155     $ 1.90